Rilpivirine
Back to searchMolecule Structure
Scientific Name
Rilpivirine
Description of the Drug
Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with other antiretrovirals to specifically treat human immunodeficiency virus type 1 (HIV-1).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08864
http://www.drugbank.ca/drugs/DB08864
Brand Name(s)
Edurant
Company Owner(s)
Janssen Products Lp, Viiv Healthcare Co, Gilead Sciences Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Human immunodeficiency virus type 1 reverse transcriptase | SINGLE PROTEIN | INHIBITOR | CHEMBL247 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL385113 | ||
Human Metabolome Database | HMDB0061725 | ||
DrugBank | DB08864 | ||
PubChem: Thomson Pharma | 14926256 | ||
PubChem | 6451164 | ||
LINCS | LSM-45777 | ||
Nikkaji | J2.980.206H | J2.576.528A | |
PDBe | T27 | ||
BindingDB | 222178 | ||
EPA CompTox Dashboard | DTXSID10198189 | ||
DrugCentral | 4174 | ||
Brenda | 61803 | 146979 | 165598 |
ChemicalBook | CB81454833 | ||
rxnorm | EDURANT | RILPIVIRINE | RILPIVIRINE HYDROCHLORIDE |
ChEBI | 68606 | ||
ZINC | ZINC000001554274 |